ALX Oncology Holdings Inc.

NASDAQ:ALXO

0.9594 (USD) • At close March 12, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024202320222021202020192018
Operating Activities:
Net Income -134.85-160.805-123.482-83.463-45.74-19.243-13.731
Depreciation & Amortization 0.8720.8360.3420.0510.2020.4290.431
Deferred Income Tax 00001.27100
Stock Based Compensation 27.09326.27323.83913.9145.4360.2970.269
Change In Working Capital -12.438.2979.85-4.0270.2474.257-0.159
Accounts Receivables 00000.5360.396-0.932
Inventory 0000-0.536-0.3960
Accounts Payables -4.0240.4584.5063.29-3.7442.976-0.269
Other Working Capital -8.4067.8395.344-7.3173.9911.2810.11
Other Non Cash Items -2.597-4.9650.2285.4240.2950.0112.332
Operating Cash Flow -121.912-130.364-89.223-68.101-38.289-14.249-13.19
Investing Activities:
Investments In Property Plant And Equipment -0.447-1.274-1.427-4.923-0.031-0.353-0.653
Acquisitions Net 000.23400.64100
Purchases Of Investments -107.406-246.629-376.7890000
Sales Maturities Of Investments 194.109292.56142.80000
Other Investing Activites 00-0.234-4.2570.64100
Investing Cash Flow 86.25644.657-235.416-4.9230.61-0.353-0.653
Financing Activities:
Debt Repayment -0.827-0.3889.612-0.281-6.5065.9170
Common Stock Issued 058.8870.9032.753368.2560.010
Common Stock Repurchased 0.35100.3360.20200-0.006
Dividends Paid 0000-0.00300
Other Financing Activities 31.6440.7920.2482.753104.689.440.007
Financing Cash Flow 30.81759.2919.862.472462.88115.3570.001
Other Information:
Effect Of Forex Changes On Cash 0000000
Net Change In Cash -4.839-26.416-314.779-70.552425.2020.755-13.842
Cash At End Of Period 17.63322.47248.888363.667434.2199.0178.262